share_log

HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $28

HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $28

HC Wainwright & Co.维持对Corcept Therapeutics的买入,将目标股价下调至28美元
Benzinga ·  01/02 13:21

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and lowers the price target from $34 to $28.

HC Wainwright & Co. 分析师Swayampakula Ramakanth维持Corcept Therapeutics(纳斯达克股票代码:CORT)的买入并将目标股价从34美元下调至28美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发